Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Avenue Therapeutics, Inc. (ATXI) had Operating Cash Flow per Share of $-6.97 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-11.65M |
|
-- |
|
-- |
|
$11.28M |
|
$-11.28M |
|
$-0.41M |
|
$-11.70M |
|
$-11.70M |
|
$-11.70M |
|
$-11.70M |
|
$-11.70M |
|
$-11.70M |
|
$-11.28M |
|
$-11.28M |
|
1.29M |
|
1.29M |
|
$-15.79 |
|
$-15.79 |
|
| Balance Sheet Financials | |
$2.67M |
|
-- |
|
-- |
|
$2.67M |
|
$0.82M |
|
-- |
|
-- |
|
$0.82M |
|
$1.86M |
|
$1.86M |
|
$1.86M |
|
2.11M |
|
| Cash Flow Statement Financials | |
$-9.03M |
|
-- |
|
$9.84M |
|
$1.78M |
|
$2.59M |
|
$0.81M |
|
$1.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-630.17% |
|
-630.17% |
|
-437.72% |
|
-630.17% |
|
$0.88 |
|
$-6.97 |
|
|
Operating Cash Flow per Share |
$-6.97 |